We also characterized in detail the variants in five genes of particular clinical interest, BRCA1, BRCA2, KRAS, TP53, and PTEN. The results can serve as a reference for variation in the 158 cancer-susceptibility genes in the general population and have important implications for the interpretation of clinical WGS/WES. This evidence concerns the gene BRCA2 and cancer.